These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9636642)

  • 1. Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center.
    Schneeberger H; Zanker B; Hillebrand G; Illner WD; Rothenpieler U; Land W
    Transplant Proc; 1998 Jun; 30(4):1598-9. PubMed ID: 9636642
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
    Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
    Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
    [No Abstract]   [Full Text] [Related]  

  • 3. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
    Forsythe J
    Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049
    [No Abstract]   [Full Text] [Related]  

  • 4. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
    Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
    Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
    [No Abstract]   [Full Text] [Related]  

  • 5. Tacrolimus therapy for ABO-incompatible kidney transplantation.
    Takahashi K; Saito K; Sonda K; Nakagawa Y; Katagiri A; Tomita Y; Tanigawa T; Takeda M
    Transplant Proc; 1998 Jun; 30(4):1219-20. PubMed ID: 9636495
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
    Kokado Y; Takahara S; Kyo M; Ichimaru N; Toki K; Wang JD; Okuyama A
    Transplant Proc; 1999; 31(1-2):1151-4. PubMed ID: 10083515
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk".
    Braun F; Lorf T; Schütz E; Canelo R; Hanack U; Döpkens K; Sattler B; Grupp C; Ringe B
    Transplant Proc; 2000 Nov; 32(7):2535. PubMed ID: 11120281
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart-beating donors.
    Fukuhara N; Ono Y; Kinukawa T; Hattori R; Nishiyama N; Yamada S; Kamihira O; Ohshima S
    Transplant Proc; 2002 Aug; 34(5):1577-9. PubMed ID: 12176492
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients.
    Braun F; Lorf T; Grupp C; Schütz E; Sattler B; Canelo R; Müller GA; Ringe B
    Transplant Proc; 1998 Jun; 30(4):1221-3. PubMed ID: 9636496
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of delayed graft function on cadaveric kidney transplant outcome.
    Gentil MA; Alcaide MP; Algarra GR; Pereira P; Toro J; González-Roncero F; López M; Bernal G; Mateos J
    Transplant Proc; 2003 Mar; 35(2):689-91. PubMed ID: 12644095
    [No Abstract]   [Full Text] [Related]  

  • 11. Cadaveric renal transplantation against a positive historic crossmatch under tacrolimus immunosuppression: long-term follow-up.
    Lyne JC; Vivas CA; Shapiro R; Scantlebury VP; Hakala TR; Starzl TE; Jordan ML
    Transplant Proc; 1997; 29(1-2):312. PubMed ID: 9123015
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of antithymocyte globulin induction treatment on renal transplant outcome.
    Sanchez-Fructuoso AI; Naranjo P; Torrente J; Fernández-Pérez C; Avilés B; Prats D; Barrientos A
    Transplant Proc; 1998 Aug; 30(5):1790-2. PubMed ID: 9723284
    [No Abstract]   [Full Text] [Related]  

  • 13. ATGAM versus OKT3 induction therapy in cadaveric kidney transplantation: patient and graft survival, CD3 subset, infection, and cost analysis.
    Kumar MS; Cahill K; Kumar AM; Panigrahi D; Seirka D; Singleton R; al-Abdullah IH; Laskow DA
    Transplant Proc; 1998 Jun; 30(4):1351-2. PubMed ID: 9636549
    [No Abstract]   [Full Text] [Related]  

  • 14. Current advantage of FK 506 in cadaveric kidney transplantation.
    Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor.
    Kinukawa T; Ohshima S; Ono Y; Fujita T; Hattori R; Tanaka K
    Transplant Proc; 1998 Jun; 30(4):1227-9. PubMed ID: 9636498
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome of tacrolimus-treated renal transplantation from elderly donors.
    Goto Y; Tanabe K; Tokumoto T; Kondo T; Ishikawa N; Toma H
    Transplant Proc; 2000 Nov; 32(7):1723-5. PubMed ID: 11119908
    [No Abstract]   [Full Text] [Related]  

  • 17. Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation.
    Kliem V; Radermacher J; Hiss M; Pethig M; Burg M; Brunkhorst R
    Transplant Proc; 1999 Nov; 31(7A):37S-40S. PubMed ID: 10576041
    [No Abstract]   [Full Text] [Related]  

  • 18. Living-related versus living-unrelated kidney transplantation using tacrolimus initial immunosuppression.
    Braun F; Canelo R; Lorf T; Schütz E; Grupp C; Müller GA; Ringe B
    Transplant Proc; 2000 Feb; 32(1):115-6. PubMed ID: 10700989
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
    Suzuki K; Tanabe K; Tokumoto T; Shimizu T; Ishikawa N; Yagisawa T; Honda K; Nihei H; Toma H
    Transplant Proc; 2000 Nov; 32(7):1730-2. PubMed ID: 11119910
    [No Abstract]   [Full Text] [Related]  

  • 20. Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy.
    Pascual J; Ortuño J;
    Transplant Proc; 2002 Feb; 34(1):89-91. PubMed ID: 11959198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.